VMD · XBRL financial data

Viemed Healthcare financial statements, every fiscal year

The same tables from 7 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal years (VMD's year ends in late December)

In thousands of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Revenue	131,309	117,062	138,832	183,008	224,257	270,280
Cost of goods and services sold	51,198	43,652	54,152	70,225	91,054	114,822
Gross profit	80,111	73,410	84,680	112,783	133,203	155,458
Research and development	1,083	2,110	2,696	2,782	3,068	3,017
Selling, general and administrative	52,829	54,893	68,161	87,884	106,199	121,366
Operating income (loss)	26,781	11,580	8,252	14,330	17,900	22,949
Other income (expense)	3,952	1,622	989	98	(173)	252
Income tax expense (benefit)	(5,167)	3,377	2,768	4,148	4,761	6,391
Net income (loss)	31,530	9,126	6,222	10,243	11,265	14,934
Earnings per share, basic USD per share	0.81	0.23	0.16	0.27	0.29	0.38
Earnings per share, diluted USD per share	0.78	0.22	0.16	0.25	0.28	0.37
Weighted average shares, basic thousands of shares	38,744	39,491	38,655	38,354	38,755	38,895
Weighted average shares, diluted thousands of shares	40,526	40,681	39,807	40,379	40,805	40,824

Fiscal years (VMD's year ends in late December)

In thousands of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Cash and cash equivalents	30,981	28,408	16,914	12,839	17,540	13,501
Accounts receivable	12,373	12,823	15,379	18,451	24,911	25,586
Inventory	2,310	2,457	3,574	4,628	4,320	5,047
Prepaid and other current assets	1,511	1,729	3,849	2,449	6,109	4,132
Total current assets	47,175	47,310	39,742	38,367	52,880	48,493
Property and equipment, net	55,056	62,846	67,743	73,579	76,279	78,775
Right-of-use asset	—	—	694	2,872	2,831	3,580
Goodwill	—	—	0	29,765	32,989	58,938
Total assets	112,560	117,962	117,043	154,895	177,069	199,154
Accrued liabilities	12,595	8,875	11,092	17,578	20,157	23,910
Current portion of long-term debt	1,836	1,480	0	1,072	409	1,090
Total current liabilities	23,017	17,811	18,861	32,124	37,326	41,056
Long-term debt	5,796	4,306	0	6,002	3,589	11,291
Lease liability, non-current	—	—	199	2,184	2,007	2,364
Total liabilities	30,867	23,142	19,949	41,000	43,768	55,633
Retained earnings	65,643	73,335	69,846	79,495	89,691	102,891
Total stockholders' equity	81,693	94,820	97,094	113,895	131,393	141,545
Total liabilities and equity	112,560	117,962	117,043	154,895	177,069	199,154
Common shares outstanding (cover page) thousands of shares	39,562	39,680	38,169	38,757	39,522	38,603

Fiscal years (VMD's year ends in late December)

In thousands of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Net income (loss)	31,530	9,126	6,222	10,243	11,265	14,934
Stock-based compensation	4,882	5,150	5,202	5,849	6,285	9,132
Depreciation and amortization	—	—	15,630	21,862	25,368	28,613
Net cash from operating activities	35,110	22,494	27,748	45,212	39,089	51,916
Purchases of property and equipment	13,044	19,743	22,898	26,093	37,771	39,985
Net cash from investing activities	(8,415)	(19,746)	(23,976)	(52,113)	(30,699)	(50,166)
Share repurchases	0	1,434	9,568	0	0	13,225
Net cash from financing activities	(9,069)	(5,321)	(15,266)	2,826	(3,689)	(5,789)
Net change in cash	17,626	(2,573)	(11,494)	(4,075)	4,701	(4,039)

SIC 8090 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 8090 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
* marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.

Company	Cash ($K)	Revenue, quarter ($K)	Operating cash flow, quarter ($K)	Shares outstanding	Quarter
Viemed Healthcare	9,676	80,673	11,487*	37.9M	Q3 FY26 10-QSep 30, 2026
Park Dental Partners	24,398	66,212	4,690*	4.8M	Q2 FY26 10-QJun 30, 2026
Quipt Home Medical	10,543	80,996	8,941	44.5M	Q1 FY26 10-QDec 31, 2025
agilon health	174,399	1,519,486	49,872*	16.8M	Q3 FY26 10-QSep 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.